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ABSTRACT 
 
Need for novel, innovative strategies for developing antibiotics is becoming a 
necessity due to an increasing number of rapidly evolving micro-organismal threats. 
Antibiotic encapsulated gold nanoparticles (GNPs) are one such strategy showing 
promise. We report the development of ampicillin encapsulated gold nanoparticles (Amp-
GNPs) that possess highly effective, dose dependant antibacterial activity. In this method, 
ampicillin molecules have been coated on individual GNPs which can then serve as drug 
carrier devices. Our method for synthesizing Amp-GNPs is an entirely ecofriendly, single 
step reaction taking place in an aqueous buffer. Following characterization of Amp-
GNPs, we find them to be ~15 nm in diameter and spherical in shape. We have tested the 
antibacterial activity of Amp-GNPs against multiple strains of bacteria, both Gram-
positive and Gram-negative, and have found Amp-GNPs to be highly efficient against all 
tested strains. By examining the mechanism of Amp-GNPs antibacterial activity, it was 
determined that Amp-GNPs disrupt the bacterial cells membrane when coming into 
contact with the cells, thus disturbing the cell equilibrium, leading to cell lysis or 
necrosis. Amp-GNPs have been shown to exhibit significant potential and ability to enter 
the medical field’s arsenal to fight infectious disease. 
 
Keywords: Ampicillin, gold nanoparticles, antibacterial, drug carrier, green synthesis 
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CHAPTER 1 
 
 
INTRODUCTION 
 The fields of antibiotics and medicine are constantly evolving and changing in 
order to adapt to the threat of micro-organismal disease as well as numerous other 
medical complications [1, 2]. Ampicillin, a derivative of penicillin, introduced in 1961 
has been an effective antibacterial agent against both Gram positive and Gram negative 
bacteria, remedying numerous bacterial infections and saving countless lives [3]. 
Recently, however, a number of microorganisms have developed strong resistance 
towards ampicillin and other antibiotics negating the antibiotics effectiveness as broad 
spectrum antibiotics [3-6]. With this rising threat, the need for antibiotics to be readily 
transported to the site of drug action has rapidly increased [7, 8].  
Drug carriers are substances designed to aid in the transport of antibiotics 
throughout the body. With use of drug carriers to transport antibiotics it is far more likely 
the antibiotics will have greater efficacy, delivery and less toxicity [9]. Drug carriers have 
several properties giving them advantages over traditional antibiotic prescription alone 
[2, 10]. In this context, nanoparticles offer distinct advantages as drug carriers. Drug 
accuracy is possible due to the surface area to volume ratio of the nanoparticle allowing 
potentially millions of antibiotic molecules to be attached to a single nanoparticle [9, 11]. 
The use of nanoparticle based drug carriers can potentially save an exorbitant amount of 
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capital as well as drastically improve the quality of antibiotic administered [9]. Though 
many elements can be used for nanoparticle synthesis gold nanoparticles (GNPs) are 
most ideal, due to non-cytotoxicity, stability and biocompatibility in contrast to other 
metallic nanoparticles such as zinc and silver [11]. Potential drug carrier and target cell 
delivery capabilities of GNPs make their use as antimicrobial agents highly ideal and 
sought after [12-14]. Due to their high stability and small size GNPs possess the ability to 
extend the biological half life as well as bioavailability of administered antibiotics. This 
ability effectively decreases the amount of antibiotic required for administration and 
increases the likelihood of remediation of infectious disease. Being effective drug carriers 
GNPs would possess the capabilities mentioned previously of cost effectiveness, accurate 
drug delivery, and overall antimicrobial efficiency [9].  
To obtain antibiotic conjugated NP, especially GNP, various strategies have been 
employed. Most of these strategies involve functionalization of GNP using different 
linkers such as amino acids, glutathione, polyethylene glycol [15, 16]. But sometimes 
addition of linker may either reduce the efficacy of the antibiotics or may also interfere 
with the stability of drugs [15-17]. Recently two different strategies have been shown to 
fabricate ampicillin conjugated gold nanoparticles without using linkers [18, 19]. Both of 
these strategies used either citrate or sodium borohydride for the formation of gold 
nanoparticles. However, a potential toxicity of GNPs produced by citrate method have 
been demonstrated, moreover the toxicity of sodium borohydride is also evidences [20-
22]. Thus use of above mentioned chemicals for the synthesis of GNPs, not only makes 
the synthesis process nonecofriendly but also have potential toxicity on human health. To 
avoid all the disadvantages and potential risk, we have used a novel strategy of 
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completely green synthesis of ampicillin coated gold nanoparticles (Amp-GNP), in single 
step synthesis without using any linker or hazardous organic solvents.  
In continuation of our research efforts centered on the development of innovative 
gold nanoparticles for use as antimicrobial agents, we report the completely green 
synthesis of gold nanoparticles (GNPs) individually coated with the antibiotic ampicillin. 
GNPs serve as drug carriers which might deliver the antibiotic to targeted locations 
minimizing the risk of over-dose and potentially revolutionizing medicine [9]. Synthesis 
of the Amp-GNPs is entirely eco-friendly involving a single-step synthesis method where 
the ampicillin serves as both the reducing and capping agent within an 
aqueous medium. Successful synthesis of Amp-GNPs has proven the effectiveness of the 
antibiotic ampicillin to serve as an efficient reducing agent in the reduction of Au
3+
 to 
Au
0 
within medium. The medium used in the synthesis is an aqueous medium. The novel 
synthesis process we have developed is advantageous over traditional GNP synthesis 
methods allowing the GNPs to engage in biomedical applications and is a single-step 
synthesis procedure further improving the GNPs’ economical value and efficiency. 
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CHAPTER 2 
 
 
MATERIALS AND METHODS 
 
2.1. Reagents and material:   
  Chemicals including KAuCl4/HAuCl4, ampicillin, Lysogeny Broth (LB) agar, 
and Tryptic Soy (TS) agar were purchased from Aldrich, St. Louis, MO. The various 
bacterial strains were either purchased from Invitrogen, Carlsbad, CA or obtained from 
the biological specimen collection at Western Kentucky University. Analytical grade 
chemicals were used.  
 
2.2. Synthesis of Antibiotic Coated GNPs:  
 Ampicillin encapsulated gold nanoparticles (Amp-GNPs) were synthesized by the 
reduction of Au
3+
 ions to Au
0
 using the antibiotic ampicillin with environmentally 
friendly buffer solution [pH ~ 7.2 ± 0.2]. For the synthesis, 0.28 mM ampicillin solution 
and 400 PPM KAuCl4 was mixed in buffer solution. Upon mixing, the container 
enclosing the solution was placed into an orbital shaker gyrating at ~150 rpm at room 
temperature for approximately 24 hours [23]. A color change resulted within 12 hours of 
incubation. The color change was from a clear solution to violet. The change in color 
denoted the formation of nanoparticles and hence the reduction of Au
3+
 to Au
0
 and the 
formation of the ampicillin encapsulated gold nanoparticles. For processing of the Amp-
GNPs, centrifugation at 12000 rpm for 20 minutes allowed the separation of formed 
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Amp-GNPs from excess ampicillin solution and buffer located in the supernatant. After 
discarding the supernatant the remaining precipitate was thoroughly washed with 
nanopure water several times and used for further analysis [23]. 
 
2.3. Characterization of Antibiotic Coated GNPs:  
 With the use of PerkinElmer’s LAMBDA 35 UV/Vis absorption spectra the Amp-
GNPs were analyzed for their optical properties. JEOL-TEM Transmission electron 
microscopy (TEM) was used to determine the morphological characteristics of the Amp-
GNPs. Samples for the TEM images were prepared by placing a 4 µL Amp-GNPs 
solution onto a 400 mesh size formvar coated copper grid and air drying them for 5 
minutes. Excess water was removed using a filter paper wedge. In determination of the 
Amp-GNPs’ elemental properties electron dispersive x-ray spectroscopy (EDS) was 
conducted using JEOL-JSM-S400 LV with IXRF system. Samples for EDS were placed 
onto an aluminum stub and allowed to dry in a desiccator before examination. 
 
2.4. Antibacterial Activity of Amp-GNPs: 
In determination of the Amp-GNPs efficacy as an antibacterial agent, both liquid 
broth turbidimetry and solid agar plate based assays were employed. These experiments 
were performed against multiple strains of bacteria representing both Gram-positive such 
as Staphylococcus epidermidis, Streptococcus bovis and Gram-negative strains such as 
Pseudomonas aeruginosa, and Enterobacter aerogenes. In the turbidimetry assay the 
Amp-GNPs were inoculated with 105 CFU/mL in a series of test tubes containing 4 mL 
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of sterile liquid media. A control was made by inoculating the media with bacterial cells 
in absence of Amp-GNPs. All tubes were incubated at 37 ºC for 12 hours. After every 
hour of incubation the optical density (OD) at a wavelength of 600 nm of both the control 
and all samples was examined and recorded. Any absorbance due to the Amp-GNPs or 
the medium was autocorrected using a blank of Amp-GNPs dispersed in the medium, in 
absence of bacterial organism. Following turbidimetry assays solid agar assays were 
performed [24].The bacterial suspensions were centrifuged at 4000 rpm, the pellet was 
resuspended in 500 μL DPBS and spread onto fresh, solid, nutrient rich agar plates 
(Luria-Bertani agar / tryptic soy agar). The plates were then allowed to incubate for 12 
hours at 37 °C during which time the bacterial colonies became visibly populated. The 
bacterial colonies were then counted for examination of results [25, 26]. The number of 
colony forming units was established by taking average of counts from three or more 
independent experiments.  
 
2.5. Amp-GNPs Antimicrobial Mechanism Examination:  
 To determine the mechanism of the Amp-GNPs antibacterial activity, propidium 
iodide testing was conducted using both Gram-positive and Gram-negative bacterial 
strains [14,27]. Propidium iodide is a chemical dye that fluoresces upon interacting and 
binding with nucleic acids. Notably, propidium iodide is impermeable to an intact, 
healthy cell wall. Therefore, organismal solutions with intact cell walls will yield a low 
level of fluorescence while lysed organismal solutions will fluoresce excessively. 
Bacterial organisms were cultured in liquid media samples in the presence of Amp-GNPs 
at minimum inhibitory concentrations, which was determined from turbidimetry and from 
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spread plate assay. Samples were collected and centrifuged at 6000 rpm for 3 minutes 
and washed twice with PBS saline buffer (pH~ 7.2). These bacterial cells were incubated 
with 10 mM propidium iodide in a dark environment for 30 minutes at room temperature. 
After incubation, the samples were washed using PBS to get rid of any excess, unbound 
dye for reducing the background fluorescence. For sampling, 10 µL of the bacterial 
suspension was placed on a glass slide, mounted with a cover slip and observed under a 
Leica fluorescence microscope. The bacterial suspension without Amp-GNPs was used 
as a control. The percentage of fluorescent cells was established by taking average counts 
from five or more fields of view from three independent experiments.  
To visualize the morphology of the bacteria after exposure to Amp-GNPs, cross 
sectional analysis was performed with the aid of TEM. Bacterial cell samples exposed to 
minimum inhibitory concentrations of Amp-GNPs were collected at different time points 
and processed for sectioning. Controls were made by inoculating the media with bacteria 
in absence of Amp-GNPs. All tubes were incubated at 37 ºC for 12 hours. Sample of 1 
mL was collected at different time points from the test tubes and centrifuged at 6000 rpm 
for 3 minutes. All the samples were thoroughly washed with nanopure water and then 
placed onto Formvar coated 400 mesh size copper grids and observed under JEOL-TEM. 
For cross-section analysis, bacterial cell cultures were fixed using 16 % w/v 
paraformaldehyde and 10 % w/v gluteraldehydeas primary fixing agents in 50 mM 
sodium cacodylatebuffer (pH ~ 7.4) and incubated for 2 hours in the hood. The fixed 
samples were washed thoroughly using the buffer solution and post fixed using 1 % 
osmium tetroxide (OsO4) and incubated for 1 hour at room temperature. The post-fixed 
samples were then thoroughly washed with nanopure water followed by the treatment of 
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graded ethanol series (25, 50,75, 95 and 100 %) for 5-10 minutes. The dehydrated 
samples were further infiltrated by incubation in a graded series of Spur’s epoxy resin 
(33, 66, 95 and 100 %) for 1 hour and left overnight in a fresh 100 % resin. The samples 
were centrifuged through fresh resin in BEEM capsules and hardened at 70 °C for 18 
hours. Ultra-thin sections of the pelleted samples were cut on an RMC MT-X ultra-
microtome using glass knife. Sections were stained with 2 % aqueous uranyl acetate and 
Reynold’s lead citrate for 15 minutes and 3 minutes respectively and examined using a 
JEOL-100CX TEM. 
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CHAPTER 3 
 
 
RESULTS 
 
 3.1. Amp-GNP Synthesis and Characterization:  
 For Amp-GNP synthesis gold salt (KAuCl4) concentration of 400 PPM and 0.28 
mM ampicillin antibiotic solution were mixed within aqueous buffer. Upon mixing the 
contents the container in Erlenmeyer flask enclosing the solution was then placed into a 
gyrating orbital shaker at a temperature of 37 °C for 12 hours under normal atmospheric 
pressure. The solution of Amp-GNPs changed in color after 12 hours. With the use of 
UV/Vis absorption spectra the Amp-GNPs were analyzed for their optical properties. The 
antibiotic encapsulated GNPs were found to express a λ max value at 540 nm as shown in 
“Figure 1A”. Transmission electron microscopy (TEM) was used to determine the 
morphological characteristics of the Amp-GNPs which showed formation of near 
spherical shaped nanoparticles with approximately 15 ± 5 nm in diameter, “Figure 1B”. 
In determination of the Amp-GNPs elemental properties, electron dispersive X-ray 
spectroscopy (EDS) was conducted. Results showed the anticipated high percent value of 
Au
0
 (85 %) as well as a C (8%), O (5%), and S (2%) peak as shown in “Figure 1C”. 
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Figure 1. (A). UV-vis spectrum of Amp-GNPs with notable absorbance peak at ~540 
nm. (B). Transmission electron microscope images of Amp-GNPs with average diameter 
of 15 nm. (C). Scanning electron microscope image and electron dispersion spectrum of 
Amp-GNPs. EDS shows the Amp-GNPs to be ~ 85% Au, ~ 8 % C, ~ 5 % O, and ~ 2 % 
S. 
 
 
 
3.2. Antibacterial Activity of Amp-GNPs:    
  In assessment of the Amp-GNPs antimicrobial activity bacterial assays were 
performed against two strains of both Gram-positive bacteria (Staphylococcus 
epidermidis, and Streptococcus bovis) and Gram-negative (Enterobacter 
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aerogenes and Pseudomonas aeruginosa). Results from the liquid broth turbidimetry 
assay exhibited the Amp-GNPs to possess significant dose dependant bacteriostatic 
activity against Staphylococcus epidermidis and Enterobacter aerogenes 
as shown in “Figure 2A & 2B”, respectively. In addition, the turbidimetry assay allowed 
for the determination of the minimum inhibitory concentration (MIC) of each tested 
organism. For Staphylococcus epidermidis, a Gram-positive bacteria the MIC was found 
to be ~0.130 mg/mL while the MIC was ~0.510 mg/mL for Enterobacter aerogenes, a 
Gram-negative bacteria.  
To discern whether or not the Amp-GNPs embody bactericidal activity alongside 
bacteriostatic activity, solid agar plate based assays were performed. The results from the 
solid agar plate based assay indicated the Amp-GNPs possess highly effective 
bactericidal activity. This was indicated by the abundance of bacterial colonies on control 
plates while plates treated with Amp-GNPs contained only scarce numbers of bacterial 
colonies as illustrated in “Figure 3 I & II”. In further pursuit of the Amp-GNPs broad 
spectrum efficacy as an antimicrobial agent the spread plate assay was repeated 
using additional strains. The additional bacterial strains were found to express similar 
results, Supplementary “Figure 1A & 1B”.  
Additional antimicrobial tests were performed using just the antibiotic ampicillin. 
Spread plate assays against the same organisms tested against Amp-GNPs were used. 
Results from the experiment illustrated the effectiveness of ampicillin against these 
strains, “ Supplementary Figure 2A, B, C” and the MIC of ampicillin against 
Enterobacter aerogenes was determined to be ~2.3 mg/mL, for Pseudomonas aeruginosa 
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was ~1.9 mg/mL, for Staphylococcus epidermidis was ~1.5 mg/mL, and for 
Streptococcus bovis was ~1.4 mg/mL respectively, as shown in “Table 1”. 
 
 
 
Figure 2. A. Growth curve of Staphylococcus epidermidis when exposed to various 
concentrations of Amp-GNPs. From top to bottom the concentrations are 0.008 mg/mL, 
0.016 mg/mL, 0.033 mg/mL, 0.067 mg/mL, 0.08 mg/mL, 0.096 mg/mL, and 0.133 
mg/mL. Minimum inhibitory concentration (MIC) was determined to be ~ 0.130 mg/mL. 
B. Growth curve of Enterobacter aerogenes when exposed to various concentrations of 
Amp-GNPs. From top to bottom the concentrations are 0.016 mg/mL, 0.033 mg/mL, 
0.067 mg/mL, 0.133 mg/mL, 0.256 mg/mL, and 0.512 mg/mL. Minimum inhibitory 
concentration (MIC) was determined to be ~ 0.500 mg/mL. 
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Figure 3. Panel-I-A. Spread plate assay for Staphylococcus epidermidis with (untreated) 
control and increasing Amp-GNPs concentrations. B. Graph of number of S. epidermidis 
colonies versus concentration of Amp-GNPs. Panel-II- A. Spread plate assay for 
Enterobacter aerogenes with (untreated) control and increasing Amp-GNPs 
concentrations. B. Graph of number of E. aerogenes colonies versus concentration of 
Amp-GNPs. 
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Table 1. Amp-GNPs and Ampicillin MIC Values MIC (Minimum Inhibitory 
Concentration) Table of Amp-GNPs and Ampicillin Against all Gram Positive and Gram 
Negative Strains Tested 
 
3.3. Amp-GNPs Antimicrobial Mechanism Examination:  
To determine the mechanism of the Amp-GNPs antibacterial activity, propidium 
iodide testing was conducted using both Gram-positive and Gram-negative bacterial 
strains. It was found that the solutions with Amp-GNPs fluoresced with far greater 
magnitude than samples without Amp-GNPs, “Figure 4”. To visualize the morphology 
of the bacteria after exposure to Amp-GNPs, cross sectional analysis was performed with 
the aid of TEM. Bacterial cell samples exposed to Amp-GNPs were collected at different 
time points and processed for sectioning. Bacteria untreated with Amp-GNPs were 
observed to have intact membranes even after 12 hours of incubation time. Amp-GNP 
treated bacteria, however, were found to show gradual morphological changes within six 
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hours time. After immediate Amp-GNP introduction (0 hour time point) the bacteria were 
observed to have the Amp-GNPs attached to their cell membrane at numerous locations. 
Within six hours time the bacterial cell began to exhibit deformations and perforations in 
its cellular membrane. At the twelve hour time point the bacterial cells were observed 
with their cell membranes completely lysed and leaking of the inner cellular components. 
All of these bacterial morphological changes were evident for both Gram-positive and 
Gram-negative bacteria, “Figure 5”. 
 
 
Figure 4. Panel-I- Monitoring Amp-GNPs induced permeability of Staphylococcus 
epidermidis cell membranes using propidium iodide dye. A. On each image, the left half 
shows an image in the differential interference contrast mode, while the right half shows 
the corresponding fluorescence image; B. Plot with percentage of permeable cells against 
concentration of Amp-GNPs. Panel-II- Monitoring Amp-GNPs induced permeability of 
Enterobacter aerogenes cell membranes using propidium iodide dye. A. On each image, 
the left half shows an image in the differential interference contrast mode, while the right 
half shows the corresponding fluorescence image; B. Plot with percentage of permeable 
cells against concentration of Amp-GNPs. 
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Figure 5. Visualization of bacterial morphological changes before and after Amp-GNPs 
exposure. A. Sequential analysis of Gram positive bacteria, Staphylococcus epidermidis. 
From left to right showing normal bacteria at 0 hour (pre Amp-GNP exposure), bacteria 
after six hours of Amp-GNP exposure showing cell membrane deformations, and after 
twelve hour of Amp-GNP exposure showing lysed cell. B. Sequential analysis of Gram 
negative bacteria, Enterobacter aerogenes. From left to right showing normal bacteria at 
0 hour (pre Amp-GNP exposure), bacteria after six hour of Amp-GNP exposure showing 
cell membrane deformations, and after hour twelve of Amp-GNPs exposure showing 
lysed cell. 
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CHAPTER 4 
 
 
DISCUSSION 
 
4.1. Synthesis and Characterization of Antibiotic Coated GNPs 
The objective was to synthesize antibiotic encapsulated GNPs that possess 
uniformity in both shape and size while still producing a yield of reasonable measure. 
The observed color change of the antibiotic encapsulated GNPs was from an 
approximately clear solution to darker shades of violet. Change in color denotes the 
formation of GNPs by reduction of gold (Au
3+
 to Au
0
) and hence the formation of the 
antibiotic ampicillin encapsulated gold nanoparticles [23]. The reduction of the gold ions 
was possible due to the number of reducing groups such as hydroxyl or amino groups on 
the ampicillin molecule.  
To examine the morphological, optical, and elemental properties of the Amp-
GNPs a variety of instruments were employed. The UV-Vis experiments on the Amp-
GNPs the maximum absorbance (λ max) value at 540 nm, the wavelength within the 
range of absorbance characteristic for GNPs, due to GNPs unique surface plasmon 
resonance [28,29]. It is the unique surface plasmon resonance of GNPs that allows this 
characterization to elucidate the approximate size of ~15 nm and spherical shape of 
GNPs. The TEM analysis of the Amp-GNPs was a critical step in assessing the 
morphological characteristics of the GNPs. The results eluded the approximate size and 
shape as previously mentioned and additionally, that the Amp-GNPs did not form 
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aggregates or any form of clusters. With the EDS results showing the elemental 
components of the Amp-GNPs, further proof of the composition of the Amp-GNPs was 
formed. The presence of the non Au peaks in the results aid in confirming the antibiotic 
ampicillin’s presence on the Amp-GNP. This is evident as the antibiotic ampicillin 
possesses the additional elements of C, O, and S within its chemical structure. 
  
4.2. Antibacterial Activity of Amp-GNPs  
As a β-lactam antibiotic, ampicillin’s mechanism of action against bacteria is 
through the binding of Penicillin Binding Proteins (PBPs) [30]. This binding in turn 
prevents the formation of the bacterial cell wall.  
Without the capability to form a cell wall the organism and subsequent infection 
will subside. However, some bacterial strains have begun to form resistances towards 
ampicillin [3]. Through the enzyme beta lactamase which breaks down ampicillin, these 
evolved strains are capable of evading the ampicillin mechanism of antimicrobial action.  
 In determination of the Amp-GNPs efficacy as an antibacterial agent, both liquid 
broth and solid agar plate based assays were employed. These experiments were 
performed against multiple strains of both Gram-positive (i.e. Staphylococcus 
epidermidis) and Gram-negative bacteria (i.e. Enterobacter aerogenes). The liquid broth 
assay was conducted by absorbing the optical density at 600 nm because of the 
correlation between the optical density of the culture and the total number of cells it 
contains. This liquid broth assay provided evidence of the Amp-GNPs bacteriostatic 
activity as well as the minimum inhibitory concentration (MIC). The MIC is the lowest 
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concentration required in order to effectively halt bacterial multiplication. Gram-positive 
and Gram-negative bacteria differ in MIC however, the discrepancy in MIC between 
Gram-positive and Gram-negative bacteria is attributed to the naturally elevated 
resilience of Gram-negative bacteria [2, 31]. The greater resilience of Gram-negative 
bacteria is due to the structural differences between both types (Gram positive and 
Gram negative) of cellular membranes. Gram-negative bacteria are equipped with 
multiple layers of phospholipids and a smaller peptidoglycan region. This multilayered 
membrane provides the Gram-negative bacteria with added resilience when compared to 
Gram-positive bacteria [14, 32-34]. Gram-positive bacteria have a single phospholipid bi-
layer and a larger peptidoglycan region. These differences in cellular anatomy explain the 
larger lack of Gram-positive bacteria ability to repel the Amp-GNP attack as effectively 
as Gram-negative bacteria [35, 36].  
The bacterial cultures used in the liquid broth turbidimetry assay were spread onto 
fresh, solid, nutrient rich agar for conduction of the solid agar assay. The Gram-positive 
bacteria, Staphylococcus epidermidis was examined along with the Gram-negative 
bacteria, Enterobacter aerogenes. The plates were then allowed to incubate for 12 hours 
during which time the bacterial colonies became visibly populated. Results indicated the 
Amp-GNPs to possess bactericidal activity. Additionally the Gram-positive 
Streptococcus bovis and the Gram-negative Pseudomonas aeruginosa strains were 
examined in order to secure the premise of the Amp-GNPs being effective broad 
spectrum antimicrobial agents. With the results for the additional strains being similar to 
the preliminary tests the Amp-GNPs we are ever more confident in the Amp-GNPs 
efficacy as an antimicrobial agent.  
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In order to compare Amp-GNPs to ampicillin alone the spread plate assay was 
performed. The organisms tested were Gram-positive bacteria Staphylococcus 
epidermidis and Streptococcus bovis and the Gram-negative bacteria organisms were 
Enterobacter aerogenes and Pseudomonas aeruginosa. The results provided the MIC’s 
for each strain. When comparing the MIC of ampicillin alone, however, it is evident that 
the Amp-GNPs are more potent in that a lower concentration is required to effectively 
neutralize bacterial growth.  
The examined antimicrobial effects of Amp-GNPs have proven them highly 
effective against multiple bacterial organisms of both Gram-positive and Gram-negative 
type. Bacterial infection is one of the most basic yet highly deadly and severe forms of 
disease. It is therefore imperative that modern medicine is equipped with the adequate 
resources necessary to thwart such threats. With these data Amp-GNPs are shown to be a 
highly promising addition to modern medicine and a potential solution to bacterial 
infection. 
 
4.3. Amp-GNP Antimicrobial Mechanism Examination 
In assessment of the antimicrobial mechanism of Amp-GNPs the fluorescence 
microscopy experiments using propidium iodide were performed. Propidium iodide is a 
chemical dye that fluoresces upon interacting and binding with nucleic acids [14, 26]. 
Notably, propidium iodide is impermeable to an intact, healthy cell wall. Therefore, 
organismal solutions with intact cell walls will yield a low level of fluorescence while 
lysed organismal solutions will fluoresce excessively. A solution composed of liquid 
broth, bacterial organism, and Amp-GNPs were treated with the chemical dye. After 
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assessing the results it was found that the solution with Amp-GNPs fluoresced 
extensively more than the control. The increased fluorescence was caused by the 
amplified chemical dye, nucleic acid interaction. The interaction was possible because of 
the Amp-GNPs ability to lyse the bacterial cell membranes allowing the release of the 
bacterial nucleic acids. With these data we have been able to unveil the mechanism of 
Amp-GNP’s bactericidal activity. The mechanism of Amp-GNP antibacterial activity is 
through the disruption of the bacterial cell wall, inhibiting the ability for the bacterial cell 
to regulate its homeostasis. Without the capability to regulate what materials enter and 
exit the cell the bacteria will inevitably die.  
Cross sectional analysis of the tested bacteria (both Gram-positive and Gram-
negative) before and after Amp-GNP exposure revealed a visual perspective of the 
destruction of the bacterial cells. Through the exposure time sequenced bacterial 
sectioned samples of initial exposure, six hours, and twelve hours it was possible to 
observe the morphological changes the bacteria underwent when confronted with the 
Amp-GNP antimicrobial attack. The gradual deformation resulting in complete lysis of 
the bacterial cell membrane provides further evidence of the mechanism behind the Amp-
GNPs antimicrobial abilities of destruction of the bacterial cell wall.  
The antibiotic ampicillin used in the green synthesis of the Amp-GNPs possesses 
a number of functional groups with chemical reduction capabilities such as hydroxyl and 
amino groups. Additionally the Amp-GNPs possess the capacity to act as both a 
hydrogen bond donor and as a hydrogen bond acceptor. This chemical property 
associated with hydrogen bonding is likely due to the electrostatic interaction that takes 
place between the antibiotic encapsulated GNP and the bacterial organism. This 
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interaction is what leads to the disruption of the bacterial cell membrane. It is speculated 
that the formation and deformation of chemical bonds associated with the bacterial cell 
membrane cause the cellular membrane breakage and the subsequent death of the 
bacterial organism. 
The mechanism of Amp-GNP bactericidal action is entirely unique. Traditional 
antibiotics utilize mechanisms that share little similarity to Amp-GNPs. With traditional 
antibiotics the mechanism of action employed often involves the blocking of one of 
several possible bacterial cell functions. It is without the ability to carry out normal 
functions that the bacterial organisms die [37-39]. However, traditional antibiotic 
mechanisms’ approach to warding off bacteria is the reason bacteria are capable of 
forming resistances or even immunities towards antibiotics. The ability of bacterial 
organisms to evolve and mutate in ways that allow the circumvention of traditional 
antibiotic attack is futile to the Amp-GNPs mechanism of action. In order to become 
resistant to the Amp-GNPs bacterial organisms would have to evolve in a way that 
essentially alters their entire anatomy in the form of the bacteria’s cell membrane. 
Therefore, antibiotic encapsulated GNPs possess a truly unique and potentially 
revolutionary mechanism of bactericidal action that has the capabilities of transforming 
the age-old practice of fighting bacterial disease [40-42].  
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CHAPTER 5 
 
 
CONCLUSION 
 
In conclusion, we report the successful synthesis of antibiotic encapsulated gold 
nanoparticles using environmentally friendly methods with the antibiotic ampicillin. In 
addition, we report the effective use of ampicillin encapsulated gold nanoparticles (Amp-
GNPs) as effective antibacterial agents. The antibacterial experiments were performed 
against multiple strains of bacteria representing both bacterial types, Gram-positive and 
Gram-negative. Amp-GNPs were found to possess highly effective, dose dependant 
antibacterial capabilities against all bacterial strains tested. The mechanism of 
antibacterial action was determined to be through the disruption of the bacterial cell 
membrane or necrosis. The lysing of the bacterial cell membrane resulted in the release 
of the bacterial cells inner components, the loss of bacterial cellular ability to regulate 
homeostasis, and the subsequent death of the bacteria. The antibiotic encapsulated gold 
nanoparticles have been shown to exhibit significant potential and ability to enter the 
medical field’s arsenal to fight infectious disease. With the additional affect of being 
multifunctional and antibacterial themselves, the antibiotic coated GNPs are truly 
revolutionary for the fields of biomedicine and pharmaceuticals and are undoubtedly part 
of future nanomedicine.   
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Supplementary Figure 1. Spread plate assay for (A) Pseudomonas aeruginosa and (B) 
Streptococcus bovis using Amp-GNPs. Images of plates show untreated control and 
increasing AMP-GNPs concentrations. Graph shows number of each respective 
organism’s colonies versus concentration of AMP-GNPs. 
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Supplementary Figure 2. Spread plate assay for (A) Staphylococcus epidermidis, (B) 
Streptococcus bovis, (C) Pseudomonas aeruginosa, and (D) Enterobacter aerogenes 
using ampicillin. Images of plates show untreated control plate followed by ampicillin 
treated plate for all three strains. Graph shows the number of bacterial colonies versus 
control (untreated sample) and the MIC of ampicillin. Data confirms MIC of ampicillin 
against the various strains as being higher than the MIC of AMP-GNPs supporting the 
idea of AMP-GNPs being more potent and efficient than the standard antibiotic 
ampicillin. 
